Literature DB >> 10721704

Analysis of the 5' end of the mouse Elavl1 (mHuA) gene reveals a transcriptional regulatory element and evidence for conserved genomic organization.

P H King1, J J Fuller, L B Nabors, P J Detloff.   

Abstract

mHuA (Elavl1) belongs to a highly conserved family of genes encoding RNA-binding proteins and has been linked to cell growth and proliferation through its regulation of mRNA stability. Here, we use an RNase protection assay to demonstrate that the mHuA transcript is relatively abundant in a range of mouse tissues, with the highest levels being found in lung and embryonic stem cells. We then cloned and mapped an 18 kb DNA fragment which encompasses the 5' end of the mHuA gene. The genomic organization in this region is similar to the neural-restricted family members, Hel-N1 (ELAVL2) and mHuD (Elavl4). The first exon is lengthy and untranslated, and the second exon, which includes the methionine start site, ends between the ribonucleoprotein motifs of the first RNA binding domain. Mapping of the mHuA transcript by primer extension demonstrated three potential transcription-initiation sites which were detected consistently among different tissues and cell lines. Analysis of the sequence flanking these sites revealed the presence of transcriptional elements including TATA, CREB, c-ets, and AP1 sites. Transfection analysis of this promoter region using a luciferase-reporter-gene assay indicated strong transcriptional activity both in HeLa and in mouse macrophage (RAW) cells which is consistent with the ubiquitous expression pattern of mHuA. Thus, while the genomic organization of mHuA is similar to the neural-restricted members of the Elav family, the promoter element differs substantially both by sequence analysis and transcriptional activity in non-neural cell types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10721704     DOI: 10.1016/s0378-1119(99)00537-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Characterization of multiple exon 1 variants in mammalian HuD mRNA and neuron-specific transcriptional control via neurogenin 2.

Authors:  Lucas M Bronicki; Guy Bélanger; Bernard J Jasmin
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

2.  Post-transcriptional control of CCAAT/enhancer-binding protein beta (C/EBPbeta) expression: formation of a nuclear HuR-C/EBPbeta mRNA complex determines the amount of message reaching the cytosol.

Authors:  Joy Cherry; Heath Jones; Vesna A Karschner; Phillip H Pekala
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

3.  Expression of the RNA-stabilizing protein HuR in ischemia-reperfusion injury of rat kidney.

Authors:  Dina A Ayupova; Mamata Singh; Ellen C Leonard; David P Basile; Beth S Lee
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-06

4.  The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.

Authors:  Lisa E Young; Sandhya Sanduja; Kristi Bemis-Standoli; Edsel A Pena; Robert L Price; Dan A Dixon
Journal:  Gastroenterology       Date:  2009-01-15       Impact factor: 22.682

Review 5.  Adaptive and maladaptive expression of the mRNA regulatory protein HuR.

Authors:  Suman Govindaraju; Beth S Lee
Journal:  World J Biol Chem       Date:  2013-11-26

6.  Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas.

Authors:  E Bonora; C Evangelisti; F Bonichon; G Tallini; G Romeo
Journal:  Br J Cancer       Date:  2006-10-31       Impact factor: 7.640

7.  M6A-Related Bioinformatics Analysis Reveals a New Prognostic Risk Signature in Cutaneous Malignant Melanoma.

Authors:  Qingxiong Yu; Hainan Zhu; Huijing Wang; Rehanguli Aimaier; Manhon Chung; Zhichao Wang; Qingfeng Li
Journal:  Dis Markers       Date:  2022-06-06       Impact factor: 3.464

8.  Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease.

Authors:  Peter R Sinnaeve; Mark P Donahue; Peter Grass; David Seo; Jacky Vonderscher; Salah-Dine Chibout; William E Kraus; Michael Sketch; Charlotte Nelson; Geoffrey S Ginsburg; Pascal J Goldschmidt-Clermont; Christopher B Granger
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.